Michael Saerens

5PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Evolutionary ecologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 13, 2026
Longitudinal Audiological and Vestibular Follow-up in Adult Cancer Patients Receiving Platinum-Based Chemotherapy.

|Oct 29, 2025
Immune Checkpoint-Induced Colitis: A Single-Center Retrospective Cohort Study.

Bengt Van Holder, Julie Vereecke, Nathan Ureel

|Jan 16, 2024
Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract: a long-term comparative study.

Tijl Vermassen, Stijn De Keukeleire, Michael Saerens

|Sep 28, 2021
Risk of Thrombo-Embolic Events in Ovarian Cancer: Does Bevacizumab Tilt the Scale? A Systematic Review and Meta-Analysis.

Michael Saerens, Emiel A De Jaeghere, Heini Kanervo

|Mar 23, 2021
Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the key.

Michael Saerens, Vibeke Kruse, Willem Lybaert

Pageof 1

Frequent Collaborators

2 joint publications

Eline Naert

2 joint publications

Sylvie Rottey

1 joint publications

Vibeke Kruse

1 joint publications

Willem Lybaert